Our Team

Pat Malloy joined Needham & Company, LLC in 2017, where he led our equity sales effort in the Boston region prior to being named Co-Director of Equity Research in November 2018. He is a member of the firm’s Operating Committee and Investment Policy Committee. Before joining Needham, Pat spent seven years at UBS as a senior producer, and nearly four years at Cowen and Company. Prior to that, he spent two years as an equities trader at Longwood Investments. He received his BA from Trinity College in History and was Captain of the school’s National Championship Squash team in 2004.

Tom Maloney joined Needham & Company in 1999. He is a member of the firm’s Operating Committee and Investment Policy Committee. Prior to being named Director of Equity Research in 2006, he worked on the institutional sales desk at Needham, helping to disseminate the firm’s research ideas to institutional investors. Tom held similar roles at Tucker Anthony, Smith Barney, and Oppenheimer before joining Needham. His career began at Pepsi Cola as a business manager. He received a B.A. in Economics from Brown University in 1988 and also earned an MBA in Finance from Columbia Business School in 1993.

Mike Cikos joined Needham & Company in 2019 and covers the Infrastructure & Analytics and Security Technology sectors. Prior to joining Needham, he served on the investment teams for buy-side organizations Systematic Financial Management and RS Investments, covering software. His previous sell-side experience includes roles as senior equity analyst at Macquarie and equity research analyst at Sidoti. Mike is a CFA charterholder, and holds a B.B.A. in Finance from the University of Notre Dame.

Ryan Koontz joined Needham & Company in 2021, covering the broadband networking, cloud communications and satellite sectors. Prior to joining Needham, Ryan covered the cloud communications and networking equity sectors at Rosenblatt Securities for 3 years and previously founded two independent research businesses at Woodside Capital and Inflection Point Research. Prior to equity research, Ryan held key management positions at Advanced Fibre Communications, Ericsson, and AT&T. Ryan holds a Bachelor of Science degree in Electrical Engineering as well an M.B.A. and M.S. in Engineering Management from California Polytechnic State University, San Luis Obispo.

John Todaro joined Needham & Company in 2021 to cover the Crypto asset and Blockchain sector. John joined Needham from TradeBlock, a crypto asset research, indexes, and analytics provider, where he was the Director of Research & Markets managing a team that conducted, analyzed, and distributed blockchain and crypto asset research. Prior to TradeBlock, he co-founded a crypto asset management fund. He has been active in the crypto and blockchain community since 2014 and has been quoted in various major media publications including the Wall Street Journal, Forbes, Reuters, CNBC, CoinDesk and others discussing his insights on the space. John began his career at Citigroup where he spent time on the Equity Sales and Residential Mortgage Securities Trading desks. John holds a B.A. from the University of Pennsylvania.

Serge Belanger joined Needham & Company in 2009, where he covers the Biotechnology sector. Prior to Needham, Serge worked as a research associate at Fulcrum Global Partners and Susquehanna International Group covering the biotech and specialty pharma healthcare sectors. Previously, Serge was part of Adolor Corporation, a biopharmaceutical company, as a senior research scientist, where he was involved with the discovery and development of novel opioid receptor targeted molecules and non-opioid pain therapeutics. Serge graduated from McGill University with a BSc, Biochemistry/Pharmacology, and an MSc, Pharmacology and Therapeutics. He obtained his MBA in Finance from the Stern School of Business at New York University.

Gil Blum, Ph.D., joined Needham & Company’s Biotech research team in August 2017. Gil joined Needham from Cadwalader Wickersham & Taft, New York oldest law firm where he was a Scientific Advisor in intellectual property law and prosecution. Prior to Cadwalader, Gil held a postdoctoral fellowship at the Memorial-Sloan Kettering Cancer Center, developing early drug candidates. Gil holds a Doctoral degree in Chemical Biology from Cornell University and a B.Sc. in Chemistry from Tel-Aviv University.

Ami Fadia joined Needham and Company in May 2021 covering Biotechnology with a focus on targeted oncology and neuroscience. Prior to joining Needham, Ami spent four years as a Managing Director and Senior Analyst at SVB Leerink and previous to that spent six years at UBS where she most recently held the position of Senior Analyst. Ami also spent time working in industry as Head of Strategy & Operations at Sandoz where she was responsible for building a high performing team responsible for strategic planning, sales force strategy, training, project management, budgeting, and business development. Ami began her career in consulting working at KPMG and then McKinsey & Company in their healthcare practice. Ami holds an MBA from the Kellogg School of Management, her Bachelor’s of Commerce from the Shri Ram College, Delhi University and is a member of the Institute of Chartered Accountants of India.

Mike Matson joined Needham & Company in 2013 covering Medical Technologies & Diagnostics. Prior to joining Needham, Mike spent nine years covering the Medical Supplies and Devices industry for Mizuho Securities and Wells Fargo Securities. He previously worked in the medical device industry for Stryker’s Orthopaedics and Endoscopy divisions in marketing and product development. Mike has received multiple awards for stock picking and earnings estimate accuracy. He was ranked first for stock picking in the Health Care Equipment & Supplies sector in the 2017 Thomson Reuters Analyst Awards. He was also ranked tenth in the TipRanks Top Ten Analysts of 2016 (across all sectors), third for earnings estimate accuracy in the Health Care Equipment & Supplies sector in the 2014 Thomson Reuters Analyst Awards, first for earnings estimate accuracy in the Health Care Equipment & Supplies sector in the 2013 Thomson Reuters Analyst Awards, second for stock picking in the Health Care Equipment & Supplies sector in the 2008 Thomson Reuters Analyst Awards, and fourth in the medical device sector for stock picking in the 2007 Wall Street Journal Best on the Street. Mike has a BS in Mechanical Engineering from North Carolina State University with a minor in Economics and a MBA from Duke University’s Fuqua School of Business with a concentration in Health Sector Management. Mike holds a medical device patent (U.S. patent 6,919,914).

David Saxon joined Needham & Company in 2017 covering medical technologies. Prior to joining Needham, David worked in asset management at firms including Merrill Lynch and Baker Avenue Asset Management. David holds an MBA from Boston University’s Questrom School of Business and a BA in Economics from Boston University. David is a CFA charterholder.

Joseph Stringer joined Needham & Company in 2017, where he covers biotechnology companies. Prior to Needham, Joseph worked as a research scientist at Ra Pharmaceuticals. He conducted postdoctoral work at Yale University, earned his Ph.D. in Chemistry from the University of Wisconsin – Madison, and received a B.S. in Chemistry from Southern Illinois University – Carbondale.

Jim Ricchiuti joined Needham & Company in 1999 and covers the Advanced Industrial Technologies and Environmental Technologies sectors at Needham, including companies in the industrial laser, instrumentation, digital manufacturing, machine vision and robotics subsectors. He joined Needham & Company’s equity research team in May 1999. Prior to joining Needham, Jim was with Lehman Brothers for over five years, where he focused on technology companies in the imaging and electronics businesses. His previous experience includes Bear Stearns from 1986 to 1993 covering a number of small-cap and mid-cap companies. He also worked at Argus Research in the mid-1980s. Jim is a graduate of St. John’s University.

Since 2009, Laura Martin has been the senior entertainment and internet analyst at Needham & Company, where she publishes research on the largest internet and media stocks in the US. Prior to Needham, Martin was the senior media analyst at Soleil Securities, where she was nationally ranked by Institutional Investor magazine as “Best of the Independent Research Boutiques” for many years, and at Credit Suisse First Boston, where she was nationally ranked by Institutional Investor in 1999, 2000, and 2001 as one of the top cable and entertainment analysts in the US. Prior to CSFB, Martin worked at Capital Research & Management, where she provided analysis and managed a portfolio of media stocks. Laura Martin received her BA from Stanford, her MBA from Harvard Business School, and she holds a Chartered Financial Analyst (CFA) as well as a Chartered Market Technician (CMT) designation.

Bernie McTernan joined Needham & Company in 2021 as a Senior Research Analyst based in NYC covering the Internet & Consumer Technology sector. Bernie has well over a decade of equity research experience on the sell and buyside. Most recently Bernie was a Senior Analyst at Rosenblatt Securities, prior to that he worked as an analyst at PineView Asset Management a TMT Hedge Fund in CT, and before that he worked in equity research at Morgan Stanley covering the TMT space.

Chris Pierce joined Needham & Company, LLC in 2020 as a research analyst covering Internet Services, transitioning from an equity trading background. He also covers Transportation Technology. Most recently, he spent four years Balyasny Asset Management trading TMT & HC out of their San Francisco office. Prior to that he spent 10 years as a trader at Ascend Capital LLC. He received his B.B.A. in Marketing from UMASS-Amherst in 1997, and an M.B.A from Pepperdine University in 1999.

Quinn Bolton has been with Needham & Company since 2004 covering communication ICs and consumer semiconductor companies. Prior to Needham, he was a senior semiconductor analyst at Oppenheimer & Co., covering large capitalization, diversified semiconductor companies. Before joining Oppenheimer, Quinn was a senior analyst at CIBC World Markets, where he covered large capitalization semiconductor, personal computer device and communication IC companies. Prior to at CIBC, he was a research associate at BT Alex. Brown and held various positions in corporate finance, equity capital markets, and equity research at Salomon Brothers. He received undergraduate degrees in Electrical Engineering and Quantitative Economics from Stanford University in 1993 and is a CFA.

Charles Shi joined Needham & Company in 2019. He became a research analyst in 2021 covering Semiconductors and Semicap Equipment. Prior to Needham, Charles spent six years at Applied Materials, where he started as a global product manager in the metal deposition products division, and later became a business development manager covering the division’s foundry accounts. Charles received a PhD in materials science and engineering and an MBA from the University of California, Berkeley, and a bachelor’s degree from Tsinghua University.

Scott Berg joined Needham & Company in 2015, where he covers the SaaS and enterprise/application software. Previously, he was senior research analyst at Northland Capital Markets covering enterprise/application software. Prior to Northland, he was senior research analyst with Feltl & Company and research analyst/associate with ThinkEquity, both with a focus on enterprise software. Before his Wall Street career, Scott held a variety of internal IT management positions for 10 years. He holds an MBA in Finance and a B.A. in Economics from the University of Minnesota.

Mike Cikos joined Needham & Company in 2019 and covers the Infrastructure & Analytics and Security Technology sectors. Prior to joining Needham, he served on the investment teams for buy-side organizations Systematic Financial Management and RS Investments, covering software. His previous sell-side experience includes roles as senior equity analyst at Macquarie and equity research analyst at Sidoti. Mike is a CFA charterholder, and holds a B.B.A. in Finance from the University of Notre Dame.

Ryan MacDonald joined Needham & Company in 2018, where he covers the enterprise software market with a focus on vertical SaaS applications. Ryan joined Needham from Dougherty & Company, where he was a senior research analyst covering vertical SaaS and business services. Prior to Dougherty, he was a senior research analyst at Wunderlich Securities, an associate research analyst at Sterne, Agee & Leach, and a research analyst/associate at Northland Capital Markets, covering a number of technology subsectors. Ryan holds a B.A. in Financial Management from the University of St. Thomas.

Ryan Koontz joined Needham & Company in 2021, covering the broadband networking, cloud communications and satellite sectors. Prior to joining Needham, Ryan covered the cloud communications and networking equity sectors at Rosenblatt Securities for 3 years and previously founded two independent research businesses at Woodside Capital and Inflection Point Research. Prior to equity research, Ryan held key management positions at Advanced Fibre Communications, Ericsson, and AT&T. Ryan holds a Bachelor of Science degree in Electrical Engineering as well an M.B.A. and M.S. in Engineering Management from California Polytechnic State University, San Luis Obispo.

Joshua Reilly joined Needham & Company in 2018 covering SaaS, application software and GovTech industries. Joshua joined Needham from Canaccord Genuity, where he was a research associate covering IoT, mobile devices and semiconductor industries. Prior to Canaccord, he was a research associate at Northland Securities, covering enterprise software. Joshua began his career at Okabena Investment Management. Joshua holds a B.B.S in Finance and Accounting from the Carlson School of Management at the University of Minnesota cum laude. In addition, Joshua was an undergraduate member of the Carlson Funds Enterprise. Joshua is a CFA charterholder.

Mayank Tandon joined Needham & Company in 2011, where he covers the financial technology and payments software and services industries. Previously, Mayank was a research analyst at Signal Hill covering the financial technology/IT services and BPO sectors. Prior to Signal Hill, he was the software and services equity research analyst/select portfolio manager at Fidelity Investments, where he led the software and services research effort and managed the select software and computer services fund for three years. Before joining Fidelity, Mayank spent several years at Janney Montgomery Scott as an analyst covering IT services companies with a focus on consulting and outsourcing. He was ranked #1 in the 2013 FT/StarMine Analyst Awards for earnings estimating in the IT Services category. He holds an M.A. in Economics from Northeastern and a B.A. in Economics from University of Bombay.